IRVINE, Calif., March 28 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. today announced that it will present at the CIBC World Markets Biotechnology & Specialty Pharmaceuticals Conference at 10:30 a.m. Eastern Time on Tuesday, April 4, 2006 at The Millennium Broadway Hotel in New York.
ISTA's Chief Financial Officer and Vice President of Corporate Development, Lauren Silvernail, will provide an update on the Company's commercial and clinical progress. To access the live audio broadcast or the subsequent archived recording log onto http://www.istavision.com. Please connect to the website several minutes prior to the start of the conference call to ensure adequate time for any software download that may be necessary.
About ISTA
ISTA is a specialty pharmaceutical company focused on the development and commercialization of unique and uniquely improved ophthalmic products. ISTA's products and product candidates seek to address serious diseases and conditions of the eye such as dry eye, vitreous hemorrhage, diabetic retinopathy, hyphema, glaucoma, ocular pain and inflammation. Building on this pipeline, ISTA's goal is to continue its growth as a specialty pharmaceutical company by acquiring complementary products, either already marketed or in late-stage development. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' Website at http://www.istavision.com.
ISTA Pharmaceuticals, Inc.CONTACT: Vince Anido, +1-949-788-5311, vanido@istavision.com, LaurenSilvernail, +1-949-788-5302, lsilvernail@istavision.com; or Justin Jackson,Media, jjackson@burnsmc.com, or Lisa Burns, Investors, lburns@burnsmc.com,both of Burns McClellan, +1-212-213-0006, for ISTA Pharmaceuticals
Web site: http://www.istavision.com/
